OctoPlus N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
22 apr 2007 - 21:08
Statutaire naam
OctoPlus N.V.
Titel
OctoPlus appoints new Scientific Advisory Board members
Bericht
OctoPlus N.V. (Euronext: OCTO), the drug delivery and development company, announces today that it has appointed three new members to its Scientific Advisory Board: professor Ab Osterhaus, professor Douwe Breimer and professor Peter van Brummelen. Current chairman professor Daan Crommelin and professor Wim Hennink will continue their work on the board. Three members will step down: professor Jan Feijen, professor Bert Leufkens and dr. Paul Morrison.
Datum laatste update: 05 maart 2026